全关节置换术后较大的初始阿片类药物处方与延长使用风险增加相关
本研究基于罗德岛处方药监测计划数据,纳入2016年1月1日至6月30日行全髋或全膝关节置换术的507例患者(全髋198例、全膝309例),评估术后初始阿片类药物处方与长期使用风险及用量的关系。结果显示,住院期间阿片剂量增加(OR 1.49/1个标准差,p=0.001)和首次门诊处方剂量增加(OR 1.26/1个标准差,p=0.049)均与延长使用风险独立相关;住院剂量增加与慢性使用风险强烈相关(OR 1.77/1个标准差,p<0.001)。作者建议尽量减少全关节置换术后住院及早期门诊阿片类药物使用,并可采用多模式疼痛管理策略。
要点
- 住院期间阿片剂量每增加1个标准差,延长使用风险OR 1.49(p=0.001)。
- 首次门诊阿片处方每增加1个标准差,延长使用风险OR 1.26(p=0.049)。
- 住院剂量每增加1个标准差,慢性使用风险OR 1.77(p<0.001)。
核心结论
- 全关节置换术后早期阿片剂量增加与延长使用风险增加相关。
- 初始门诊剂量与延长使用者和慢性使用者未来用量之间存在剂量依赖关系。
- 作者认为医疗提供者应尽量减少全关节置换术后住院和早期门诊阿片类药物使用。
- 作者建议可采用多模式疼痛管理策略以助充分镇痛同时减少阿片使用。
研究设计与样本
- 回顾性识别2016年1月1日至6月30日行全髋或全膝关节置换术的患者。
- 使用罗德岛处方药监测计划评估术前30天阿片和苯二氮䓬暴露。
- 计算术后住院期间、初始门诊阿片处方及术后31至90天(延长使用)和91至150天(慢性使用)的累计吗啡毫克当量(MME)。
- 采用回归分析评估初始术后阿片剂量与延长或慢性使用的关联,并控制人口学特征、手术类型、术前阿片和苯二氮䓬暴露、麻醉类型及周围神经阻滞使用。
- 共纳入507例患者,其中全髋198例、全膝309例。
主要发现
- 住院阿片剂量增加与延长使用风险增加独立相关(OR 1.49/住院MME每增加1个标准差,p=0.001)。
- 首次门诊处方剂量增加与延长使用风险增加独立相关(OR 1.26/初始门诊处方MME每增加1个标准差,p=0.049)。
- 住院剂量增加与慢性使用风险强烈相关(OR 1.77/住院MME每增加1个标准差,p<0.001)。
- 在30%(151/507)需要延长术后阿片的患者中,初始门诊处方剂量每增加1 MME,延长期间填充量增加0.997 MME(p<0.001)。
- 在14%(73/507)需要慢性阿片的患者中,初始门诊剂量每增加1 MME,慢性阿片剂量增加1.678 MME(p=0.008)。
临床怎么用
- 作者认为医疗提供者应尽量减少全关节置换术后住院和早期门诊阿片类药物使用。
- 作者建议可采用多模式疼痛管理策略以助充分镇痛同时减少阿片使用。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The ongoing U.S. opioid epidemic threatens quality of life and poses substantial economic and safety burdens to opioid abusers and their communities, physicians, and health-care systems. Public health experts have argued that prescription opioids are implicated in this epidemic; however, opioid dosing following surgical procedures remains controversial. The purpose of this study was to evaluate the relationship between initial opioid prescribing following total hip arthroplasty (THA) and total knee arthroplasty (TKA) and the risk and quantity of long-term opioid use. METHODS: Patients undergoing THA or TKA from January 1, 2016, to June 30, 2016, were identified. Preoperative 30-day opioid and benzodiazepine exposures were evaluated using the Rhode Island Prescription Drug Monitoring Program. Cumulative morphine milligram equivalents (MMEs) in the postoperative inpatient stay, initial outpatient opioid prescription, and prescriptions filled from 31 to 90 days (prolonged use) and 91 to 150 days (chronic use) following the surgical procedure were calculated. Regression analyses evaluated the association between the initial postoperative opioid dosing and prolonged or chronic use, controlling for demographic characteristics, procedure, preoperative opioid and benzodiazepine exposures, anesthesia type, and use of a peripheral nerve block. RESULTS: A total of 507 patients (198 who underwent a THA and 309 who underwent a TKA) were identified. Increased inpatient opioid dosing (odds ratio [OR], 1.49 per 1 standard deviation increase in inpatient opioid MMEs; p = 0.001) and increased dosing in the first outpatient prescription (OR, 1.26 per 1 standard deviation increase in initial outpatient prescription MMEs; p = 0.049) were each independently associated with an increased risk of prolonged opioid use. Additionally, increased inpatient dosing postoperatively was strongly associated with a greater risk of chronic use (OR, 1.77 per 1 standard deviation increase in inpatient MMEs; p < 0.001). Among the 30% (151 of 507) of patients requiring prolonged postoperative opioids, each 1-MME increase in the initial outpatient prescription dose was associated with a 0.997-MME increase in quantity filled during the prolonged period (p < 0.001). Among the 14% (73 of 507) of patients requiring chronic opioids, every 1-MME increase in the initial outpatient dose was associated with a 1.678-MME increase in chronic opioid dosing (p = 0.008). CONCLUSIONS: Increased opioid dosing in the early postoperative period following total joint arthroplasty (TJA) is associated with an increased risk of extended opioid use. A dose-dependent relationship between initial outpatient dosing and greater future quantities consumed by those with prolonged usage and those with chronic usage was noted. This study suggests that providers should attempt to minimize inpatient and early outpatient opioid utilization following TJA. Multimodal pain management strategies may be employed to assist in achieving adequate pain control while minimizing opioid utilization. LEVEL OF EVIDENCE: Therapeutic Level IV. See Instructions for Authors for a complete description of levels of evidence.
引用
- Ruddell JH, Reid DBC, Shah KN, et al. Larger Initial Opioid Prescriptions Following Total Joint Arthroplasty Are Associated with Greater Risk of Prolonged Use. J Bone Joint Surg Am. 2021. PMID: 33074953. doi:10.2106/JBJS.20.00732
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。